Does use of nonsteroidal anti-inflammatory drugs increase patients’ clinical severity of COVID-19?
Downloads
References
Drake TM, Fairfield CJ, Pius R, et al. Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study. Lancet Rheumatol. 2021. Epub ahead of print; PMID: 33997800; https://doi.org/10.1016/S2665-9913(21)00104-1.
Day M. Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists. BMJ. 2020;368:m1086. PMID: 32184201; https://doi.org/10.1136/bmj.m1086.
Wong AY, MacKenna B, Morton CE, et al. Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts. Ann Rheum Dis. 2021:annrheumdis-2020-219517. Epub ahead of print; PMID: 33478953; https://doi.org/10.1136/annrheumdis-2020-219517.
Lund LC, Kristensen KB, Reilev M, et al. Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study. PLoS Med. 2020;17(9):e1003308. PMID: 32898149; https://doi.org/10.1371/journal.pmed.1003308.
Manso MEG, Biffi ECA, Gerardi TJ. Prescrição inadequada de medicamentos a idosos portadores de doenças crônicas em um plano de saúde no município de São Paulo, Brasil [Inappropriate medication use in older adults with chronic diseases in a health plan in São Paulo, Brazil]. Rev Bras Geriatr Gerontol. 2015;18(1):151-64. https://doi.org/10.1590/1809-9823.2015.14056.
